Nuvectis Pharma, Inc.
NVCT
Rank in Stocks
#10496
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the... Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.
Share Price
$21.02
Last synced: 2026-11-09
Market Cap
$686.18M
Change (1 day)
0.53%
Change (1 year)
246.86%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Nuvectis Pharma, Inc. (NVCT)
Category
Healthcare
EPS for Nuvectis Pharma, Inc. (NVCT)
EPS as of September 2026 TTM: $-1.89
According to Nuvectis Pharma, Inc.'s latest financial reports, its current EPS (TTM) is $-1.89. At the end of 2025 the company had an EPS of $-1.32, a decrease compared to its 2024 EPS of $-1.11.
EPS history for Nuvectis Pharma, Inc. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.89 | 43.18% |
| 2025 | $-1.32 | 18.92% |
| 2024 | $-1.11 | -22.38% |
| 2023 | $-1.43 | -5.30% |
| 2022 | $-1.51 | 38.53% |
| 2021 | $-1.09 | 136,150.00% |
| 2020 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -928.57% |
US
|
|
| $-7.07 | 274.07% |
US
|
|
| $-5.29 | 179.89% |
AU
|
|
| $12.88 | -781.49% |
BE
|
|
| $21.56 | -1,240.74% |
NL
|
Questions about Nuvectis Pharma, Inc.'s earnings per share (EPS)
What is Nuvectis Pharma, Inc.'s earnings per share (EPS)?
Nuvectis Pharma, Inc.'s earnings per share (EPS) over the last twelve months is $-1.89, as of Sep 2026.
What was Nuvectis Pharma, Inc.'s earnings per share (EPS) in 2025?
In 2025, Nuvectis Pharma, Inc.'s earnings per share (EPS) was $-1.32, compared with $-1.11 in 2024.
How has Nuvectis Pharma, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Nuvectis Pharma, Inc.'s earnings per share (EPS) was highest in 2020 (0.00) and lowest in 2022 ($-1.51).
How does Nuvectis Pharma, Inc.'s earnings per share (EPS) compare with similar companies?
Nuvectis Pharma, Inc.'s earnings per share (EPS) ($-1.89) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.